Opiant Pharmaceuticals Inc

Company Profile

Opiant Pharmaceuticals Inc had its IPO on 2016-01-04 under the ticker symbol OPNT.

The company operates in the ENERGY & TRANSPORTATION sector and METAL MINING industry. Opiant Pharmaceuticals Inc has a staff strength of 0 employees.

Stock update

Shares of Opiant Pharmaceuticals Inc opened at $9.83 at the start of the last trading session i.e. 2022-11-02.

The stocks traded within a range of $9.62 - $10.31, and closed at $10.16.

This is a +2.63% increase from the previous day's closing price.

A total volume of 16,352 shares were traded at the close of the day’s session.

In the last one week, shares of Opiant Pharmaceuticals Inc have increased by +1.6%.

Opiant Pharmaceuticals Inc's Key Ratios

Opiant Pharmaceuticals Inc has a market cap of $0.052 billion, indicating a price to book ratio of 1.695 and a price to sales ratio of 1.363.

In the last 12-months Opiant Pharmaceuticals Inc’s revenue was $0.039 billion with a gross profit of $0.022 billion and an EBITDA of $-0.018 billion. The EBITDA ratio measures Opiant Pharmaceuticals Inc's overall financial performance and is widely used to measure its profitability.

In the trailing 12-month period, Opiant Pharmaceuticals Inc’s operating margin was -46.5% while its return on assets stood at -20.3% with a return of equity of -59.9%.

In Q2.3333333333333, Opiant Pharmaceuticals Inc’s quarterly earnings growth was a positive 273.3% while revenue growth was a negative 65.4%.

Opiant Pharmaceuticals Inc’s PE and PEG Ratio

Forward PE

26.74

Trailing PE

-

PEG

0

Its diluted EPS in the last 12-months stands at $-1.365 per share while it has a forward price to earnings multiple of 26.74 and a PEG multiple of 0. A low price to earnings ratio can mean the stock is attractively valued while a high ratio suggests the stock may be overvalued.

The PEG on the other hand provides a broader view compared to the P/E ratio and gives greater insight into Opiant Pharmaceuticals Inc’s profitability.

Opiant Pharmaceuticals Inc stock is trading at a EV to sales ratio of 0.773 and a EV to EBITDA ratio of -1.42. Its price to sales ratio in the trailing 12-months stood at 1.363.

Opiant Pharmaceuticals Inc stock pays annual dividends of $0 per share, indicating a yield of 0% and a payout ratio of 0%.

Balance sheet and cash flow metrics

Total Assets

$0.000 billion

Total Liabilities

$0.000 billion

Operating Cash Flow

$0.000 billion

Capital Expenditure

$0.000 billion

Dividend Payout Ratio

0%

Opiant Pharmaceuticals Inc ended 1970 with $0.000 billion in total assets and $131.2 billion in total liabilities. Its intangible assets were valued at $0.000 billion while shareholder equity stood at $0.000 billion.

Opiant Pharmaceuticals Inc ended 1970 with $0.000 billion in deferred long-term liabilities, $0.000 billion in other current liabilities, billion in common stock, $0.000 billion in retained earnings and $0.000 billion in goodwill. Its cash balance stood at $0.000 billion and cash and short-term investments were $0.000 billion. The company’s total short-term debt was $0.000 billion while long-term debt stood at $0.000 billion.

Opiant Pharmaceuticals Inc’s total current assets stands at $0.000 billion while long-term investments were $0.000 billion and short-term investments were $0.000 million. Its net receivables were $0.000 billion compared to accounts payable of $0.000 billion and inventory worth $0.000 billion.

In 1970, Opiant Pharmaceuticals Inc's operating cash flow was $0.000 billion while its capital expenditure stood at $0.000 billion.

Comparatively, Opiant Pharmaceuticals Inc paid $0 billion in dividends in 1970.

Other key metrics

Current Trading Price

$10.16

52-Week High

$37.71

52-Week Low

$7.34

Analyst Target Price

$40.33

Opiant Pharmaceuticals Inc stock is currently trading at $10.16 per share. It touched a 52-week high of $37.71 and a 52-week low of $37.71. Analysts tracking the stock have a 12-month average target price of $40.33.

Its 50-day moving average was $0 and 200-day moving average was $0 The short ratio stood at indicating a short percent outstanding of 0%.

Around 0% of the company’s stock are held by insiders while 0% are held by institutions.